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Abstract
 Introduction—Argentina and Uruguay have a high prevalence of smoking during pregnancy. 
However, and despite national recommendations, pregnant women are not routinely receiving 
cessation counseling during antenatal care (ANC). We evaluated a multifaceted strategy designed 
to increase the frequency of pregnant women who received a brief smoking cessation counseling 
based on the 5As (Ask, Advise, Assess, Assist, and Arrange).
 Methods—We randomly assigned (1:1) 20 ANC clusters in Buenos Aires, Argentina and 
Montevideo, Uruguay to receive a multifaceted intervention to implement brief smoking cessation 
counseling into routine ANC, or to receive no intervention. The primary outcome was the 
frequency of women who recalled receiving the 5As during ANC at more than one visit. 
Frequency of women who smoked until the end of pregnancy, and attitudes and readiness of ANC 
providers towards providing counseling were secondary outcomes. Women’s outcomes were 
measured at baseline and at the end of the 14- to 18-month intervention, by administering 
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questionnaires at the postpartum hospital stay. Self-reported cessation was verified with saliva 
cotinine. The trial took place between October 03, 2011 and November 29, 2013.
 Results—The rate of women who recalled receiving the 5As increased from 14.0% to 33.6% 
in the intervention group (median rate change, 22.1%), and from 10.8% to 17.0% in the control 
group (median rate change, 4.6%; P = .001 for the difference in change between groups). The 
effect of the intervention was larger in Argentina than in Uruguay. The proportion of women who 
continued smoking during pregnancy was unchanged at follow-up in both groups and the relative 
difference between groups was not statistically significant (ratio of odds ratios 1.16, 95% CI: 
0.98–1.37; P = .086). No significant changes were observed in knowledge, attitudes, and self-
confidence of ANC providers.
 Conclusions—The intervention showed a moderate effect in increasing the proportion of 
women who recalled receiving the 5As, with a third of women receiving counseling in more than 
one visit. However, the frequency of women who smoked until the end of the pregnancy was not 
significantly reduced by the intervention.
 Implications—No implementation trials of smoking cessation interventions for pregnant 
women have been carried out in Latin American or in middle-income countries where health care 
systems or capacities may differ. We evaluated a multifaceted strategy designed to increase the 
frequency of pregnant women who receive brief smoking cessation counseling based on the 5As in 
Argentina and Uruguay. We found that the intervention showed a moderate effect in increasing the 
proportion of women receiving the 5As, with a third of women receiving counseling in more than 
one visit. However, the frequency of women who smoked until the end of the pregnancy was not 
significantly reduced by the intervention.
 Introduction
Argentina and Uruguay are among the countries with the highest proportion of women who 
smoke during pregnancy, 10.3% and 18.3%, respectively.1 Smoking during pregnancy is 
associated with increased risks of stillbirth, preterm birth, low birth weight, restricted fetal 
growth, congenital anomalies such as cleft lip and palate, and sudden infant death 
syndrome.2,3 Maternal tobacco use is also likely to expose infants and children to 
secondhand smoke (SHS) and increase a child’s risk of becoming a smoker themselves.4 
Because smoking poses serious risks to fetal and infant health, pregnant women are an 
important population for tobacco control efforts.
Brief cessation counseling interventions, based on the 5As (Ask, Advise, Assess, Assist, and 
Arrange), are effective for smoking cessation in a wide variety of settings and populations, 
and can be delivered by various provider types.5 In a meta-analysis of 27 studies, women 
receiving smoking cessation counseling were 44% more likely to not smoke during 
pregnancy compared to women receiving usual care. Moreover, women receiving counseling 
have shown a 10%–13% reduction in infants with low birth weight or born preterm, 
although these differences were not statistically significant.6 The World Health 
Organization’s Recommendations for the Prevention and Management of Tobacco Use and 
Secondhand Smoke Exposure in Pregnancy recommend that health care providers routinely 
offer advice and psychosocial interventions for tobacco cessation to all pregnant women 
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who are either current tobacco users or recent tobacco quitters.2 National tobacco programs 
and guidelines in Argentina and Uruguay7,8 recommend a brief counseling strategy for all 
patients, including pregnant women, during antenatal care (ANC).
Despite national recommendations, women attending ANC at public maternity hospitals and 
clinics in Argentina and Uruguay are not routinely receiving brief cessation counseling. A 
survey conducted in 20 public maternity hospitals in Buenos Aires, Argentina, and 
Montevideo, Uruguay in 2010 showed that only 10% of smokers were receiving brief 
counseling during prenatal care.9 A survey conducted in Argentina in 2005, showed that 
only 22% of obstetrician/gynaecologists had received training in cessation counseling and 
48.5% reported insufficient knowledge to provide cessation advice. Although 88.9% 
consistently advised women to stop smoking, three out of four providers believed it was 
acceptable for pregnant women to smoke up to six cigarettes per day.10 Studies reporting 
barriers for the uptake of interventions for prenatal smoking cessation include competing 
demands on time, uncertainty over the effectiveness of interventions, low staff confidence in 
counseling skills, and lack of service guidelines.11
A multifaceted intervention that combines implementation of clinical practice guidelines 
with quality-improvement strategies to improve professional practice may improve 
implementation of brief counseling into routine prenatal care. While evaluation of such 
strategies have been conducted in Australia,12,13 no implementation trials of smoking 
cessation interventions for pregnant women have been carried out in Latin American or in 
middle-income countries where health care systems or capacities may differ. We report the 
results of a multicenter, cluster randomized trial in 20 public maternity care settings in the 
Province of Buenos Aires, Argentina, and in Montevideo, Uruguay that evaluated a 
multifaceted strategy to increase the frequency of pregnant women who receive brief 
cessation counseling based on the 5As.
 Methods
 Trial Design and Participants
The study was a two-arm parallel cluster randomized trial with baseline and follow-up cross 
sectional measurements conducted in a total of 20 clusters, 10 in Buenos Aires, Argentina 
and 10 in Montevideo, Uruguay. Clusters were ANC clinics serving more than 250 unique 
pregnant women per year, that did not have a smoking cessation program based on the 5As 
for pregnant women, and had physicians, midwives or nurses as part of their ANC clinic 
staff. In Argentina, each cluster consisted of a maternity hospital and one to three associated 
ANC clinics at health centers. In Uruguay, each cluster consisted of one ANC clinic at a 
health center. Health providers worked as ANC attendants in the clinic or clinics belonging 
to one cluster only. Health centers were publicly funded by the ministries of health and free 
of charge. Women attending these centers came from the most deprived economic sectors in 
both countries. More study details are published elsewhere.9,14
In the intervention clusters, midwives and obstetrician/gynaecologists interested in 
participating as facilitators of the program were trained on how to implement the 5As during 
ANC. Control clusters only received a brief seminar to increase awareness of the importance 
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of smoking cessation during pregnancy. For both countries at the time of the study, there 
were no pregnancy-specific cessation services outside of what was provided in ANC. 
Outcomes were measured during the postpartum hospital stay. Women were screened if they 
attended ANC at any of participating clinic; those who attended ANC at any of the 
participating clinics were invited to be enrolled. Participants were evaluated at a single time 
period. Data were collected during two 6-month periods: before randomization (baseline) 
and the last 6 months of the 18-month intervention (follow-up). The 24-month trial was 
conducted between October 03, 2011 and November 29, 2013.
Approval for the study was obtained from the ethics review boards of all participating local 
and partner institutions (listed in the Supplementary Appendix). Informed consent was read 
aloud to eligible women, and all eligible women provided written consent if they agreed to 
be interviewed, and if applicable, to provide a saliva sample. Responsible authorities from 
all the participating facilities signed a participation agreement. The protocol was in 
accordance with the Ottawa Statement.15 The authors confirm that all related trials for this 
intervention are registered (http://clinicaltrials.gov:NCT01852617).
 Randomization and Masking
A covariate-constrained randomization procedure16 ensured that the intervention and control 
clusters were balanced with respect to the frequency of women recalling the 5As, the 
frequency of women who smoked during pregnancy, the relative number of providers per 
women attended at the clinics, the relative frequency of midwives or nurses who attended 
ANC over the total of providers, and country of location. An independent statistician 
performed the randomization using the above covariate information from the baseline data 
collection period. Each cluster was informed of the randomization allocation after baseline 
data collection and prior to implementation of the intervention. The nature of the trial 
precluded masking of randomization allocation.
 Procedures
 Intervention Description—The intervention lasted 14–18 months. Intervention 
strategies were chosen for their effectiveness in leading to a change in practice5,17 and were 
based on the diffusion of innovation theory.18 To tailor the intervention, formative research 
was conducted with ANC clinic directors and providers (physicians, midwives, nurses), in 
nonparticipating facilities similar to the study clinics and hospitals, and with pregnant 
smokers from participating clinics.19 The results of this formative research were discussed 
among the investigators to evaluate whether the intervention components addressed the 
identified barriers, and whether those components were feasible to be implemented and 
acceptable to the health providers.
A team of ANC providers from each of the intervention clusters was trained during a 2-day 
workshop on how to implement the 5As intervention during ANC. Expert trainers in 
smoking cessation programs conducted the workshop which included a general overview of 
smoking prevalence and trends, a review of the health consequences of smoking during 
pregnancy for the mother and the newborn, and a discussion about the role of the health care 
provider in preventing smoking among pregnant women. The 5As intervention, adapted to 
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pregnant women, was explained in detail as the standard of care. After the theory was 
explained, all participants practiced communication and motivational interviewing skills in 
several role-play scenarios. During the second day of the workshop each cluster team 
developed a plan to implement the 5As program at their clinics. Two main implementation 
models were defined: (1) all ANC providers were trained to provide counseling to all 
women according to their smoking status; and (2) providers were trained to ask and provide 
brief advice to all patients, and to identify and refer smokers to a second team trained to 
provide specific counseling to smokers. Details on the implementation models at each 
intervention cluster are shown in Supplementary Appendix Table 1. It should be noted that 
both implementation models were selected by clinics within all clusters.
In the month after the workshop, the facilitators’ teams, with the support of the 5As trainers, 
replicated the training on the 5As to the rest of the providers, according to the chosen 
implementation model. Additional components of the strategy for all intervention clinics 
included printed pregnancy-specific self-help materials for the women and posters and 
reminders for waiting rooms and offices. Research staff visited the clusters on a monthly 
basis to monitor the implementation and assess completion of planned activities and to 
collect data on process measures. Some of these monitoring visits included an assessment of 
the quality of the counseling done by observation of prenatal care visits chosen at random 
and using a standardized checklist developed specifically for this purpose. This assessment 
was not intended to be representative and will not be reported quantitatively.
 Outcomes—The primary outcome was the frequency of women who recalled receiving 
the 5As among those attending ANC at the participating clinics. The recall of 5As was 
defined positive if nonsmokers and spontaneous quitters received the first two components 
of the strategy (ask and advice), and later quitters and smokers received the five components 
(ask, advice, assess, assist, and arrange) at more than one prenatal care visit. We decided to 
consider the counseling as positive if it was recalled in more than one visit because it is 
routine in prenatal care in Argentina and Uruguay to assess smoking status condition and to 
advise smokers to quit in the first visit. We also report the outcome as 5As recall in at least 
one visit. The secondary outcomes were the frequency of women who smoked until the end 
of pregnancy, and the ANC providers’ attitudes and readiness to provide smoking cessation 
counseling. Women’s outcomes were measured at baseline and follow-up in a survey 
conducted by trained interviewers within the first 48 hours after delivery, during women’s 
postpartum hospital stay. Women were eligible if they attended ANC at one of the 
participating clinics. Women with mental or physical impairments that prevented them from 
being interviewed and women with a diagnosis of stillbirth at admission were ineligible to 
participate. All consecutively eligible women who signed an informed consent were 
included until reaching the sample size. The survey included: basic demographic data 
(extracted from the clinical record); knowledge and attitudes regarding tobacco; tobacco use 
behaviors; SHS exposure; and tobacco cessation counseling received during ANC. 
Additionally, tobacco status among women who self-reported smoking cessation during 
pregnancy was validated by cotinine analysis of saliva submitted within the first 12 hours 
postpartum. Data quality and validity was periodically checked against information 
abstracted from hospital records.
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ANC providers’ outcomes were measured at baseline and during the last month of the 
intervention period. The providers completed anonymous, self-administered questionnaires 
to describe their current practice, knowledge, attitudes and self-confidence regarding 
counseling for smoking cessation and SHS exposure. The questionnaires were collected in 
opaque envelopes and placed in sealed containers at each hospital.
 Statistical Analysis—The statistical power was estimated for both primary and 
secondary outcomes, using Monte Carlo simulation20 with 3000 repetitions. The 
assumptions were: (1) the intervention and control group each contains seven clinics, with a 
minimum of 200 women at each time point, and three smaller clinics with 120 women at 
each time point; (2) an increase in the frequency of women recalling the 5As by the end of 
pregnancy from 10% to 20% in the control group and from 10% to 50% in the intervention 
group (ie, an intervention effect of 30%); (3) a decrease in the frequency of women who 
smoke at the end of the pregnancy from 18% to 17% in the control group and from 18% to 
12% in the intervention group (ie, an intervention effect of 5%); and (4) an intra-cluster 
correlation coefficient between 2 outcomes from different women at different times (pretest/
post-test) = intra-cluster correlation coefficient between two different women at the same 
time of 0.05. The value of the latter intra-cluster correlation coefficient was observed in a 
previous study carried out in Argentina and Uruguay.21
The sample size of twenty clusters (14 clusters of 200 women and six clusters of 120 women 
at each time point, respectively) would provide statistical power at the 5% level of 
significance (two-sided) of 100% for the primary outcome and 89% for the secondary 
outcome of frequency of women who were smokers at end of pregnancy.
Analyses were performed according to the intention-to-treat principle, and no cluster was 
excluded from the analysis after allocation. To test the primary hypothesis that the 
intervention would increase the frequency of women recalling the 5As during pregnancy in 
the intervention clinics compared to the control clinics, the clusters were the unit of analysis. 
We were interested in observing how the absolute difference of the percentage of women 
recalling the 5As differs between the control and intervention group. We computed the 
outcome rate for each ANC clinic at baseline and the follow-up periods, and then we 
calculated the outcome rate change as the absolute difference between the follow-up and 
baseline rates for the intervention and control groups. The median of these differences for 
the intervention and control groups was determined as the median rate change. Finally, the 
absolute difference between the median rate change in the intervention clusters and the 
median rate change in the control clusters was calculated as the intervention effect, and 
tested with the use of an exact Wilcoxon rank test. The confidence interval (CI) and P value 
were estimated using a permutation method implemented in the “wilcox.test” function in the 
R Project for Statistical Computing.22
For the second hypothesis that the intervention would decrease the frequency of women who 
smoke by the end of pregnancy, we used the woman as the unit of analysis because we 
wanted to study the effect of the intervention on the individual. For that analysis, we fit a 
model in which the variables included were the intervention (categorized as control group 
and intervention group), the time (baseline and follow-up measures) and the “intervention by 
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time” interaction. To test the effect of the intervention, we focused on the significance of the 
interaction. We used a generalized estimation equation (GEE) with a logit link to estimate 
the model and reported the effect size as an odds ratio (OR) and 95% CI. To test if the 
intervention changed providers’ outcomes, we used the same analytical approach used for 
the primary hypothesis. Those outcomes variables measured using the Likert scale were 
dichotomized in higher than 6 and 6 or less. A Z-score to percentile rank transformation was 
also used to compare the results.
To assess differences in the magnitude of the intervention effects on the rate of women 
recalling the 5As in Argentina and Uruguay, we used a median (50th quantile) regression 
analysis23 on the outcome rate change for each ANC. Independent variables were 
intervention (categorized as control group and intervention group), country, and the 
“intervention by country” interaction. These analyses involved calculating the intervention 
effect for each country and the difference of intervention effects between countries. Logistic 
regression analyses using generalized estimation equation and median regression analyses 
were completed using SAS version 9.3 (SAS Institute Inc, Cary, NC).24
 Results
 Characteristics of ANC Clinics, ANC Providers, and Women at Baseline
Twenty clusters completed baseline data collection, ten were randomized to the intervention 
group and ten to the control group (Figure 1). All 20 clusters completed the trial. The 
characteristics of the clusters and ANC providers were generally similar in the two groups 
(Table 1).
Baseline data were collected for 1562 women from the intervention group and for 1771 
women from the control group. The groups were similar with respect to maternal and 
newborn characteristics, number of ANC visits, rates of women recalling the 5As during 
ANC, and smoking status and secondhand exposure during pregnancy (Table 1). Baseline 
data were missing for less than 1% of women, with the exception of biochemically-
confirmed smoking status which was missing in 46 (2.9%) and 61 (3.4%) women who self-
reported smoking cessation in the intervention and control groups, respectively. All women 
who reported quitting and had missing biochemical confirmation at baseline and follow-up 
were considered smokers for the purpose of this analysis.
The questionnaires to ANC providers were administered at baseline to 226 and 170 
providers in the intervention and control groups, respectively. The mean response rate was 
90.2% for providers in the intervention and 96.5% for the control group.
 Intervention Process Measures
Overall, the compliance with the intervention was high. Among the intervention clusters, 
94% of the clinic providers received training in the 5As that included 49.5% physicians, 
41.6% midwives and 8.9% nurses. Most of them were female (93.6%) and trained providers 
were available during the intervention period in almost all ANC shifts (median rate 92%; 
range 60%–100%). The printed materials and reminders were distributed throughout the 
intervention period (median rate 99%; range 80%–100%), and monitoring reports were 
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conducted by clinic staff (median rate 87%; range 17%–100%). The quality of the 
counseling assessed in a nonrepresentative sample of prenatal care visits showed a 
heterogeneous quality of the 5As components, including cases in which the steps of the 5As 
were not implemented as required during the intervention training. No intervention activities 
were conducted in control clusters, and there were no changes in policies regarding smoking 
cessation during the intervention period.
 Outcome Measures
During the follow-up period, data were collected from 1793 women in the intervention 
group and from 1732 women in the control group (Figure 1). Maternal, newborn, and 
providers’ characteristics were similar to the baseline period (Table 1). Data were missing 
for less than 0.3% of the women for self-reported smoking status and 4.4% and 4.6%, for the 
biochemical confirmation of smoking status in women who self-reported smoking cessation, 
which was missing in the intervention group and in the control group. These missing values 
were due to woman who did not consent saliva extraction, women with insufficient saliva 
sample, or women with no sample.
The rate of women recalling the 5As increased from 14.0% to 33.6% in the intervention 
group (median rate change, 22.1%), and from 10.8% to 17.0% in the control group (median 
rate change, 4.6%). The size of the intervention effect, measured as the differences between 
the rate changes in the intervention and control groups, was 17.4% (95% CI: 8.5–26.8; P = .
001; Table 2). The absolute changes in rates at each individual cluster are shown in 
Supplementary Appendix Figure 1. There was a statistically significant increase in each of 
the individual components of the 5As; the difference in rate changes ranged between 14.9% 
and 29.2% for “Ask,” “Advice,” “Assess,” and “Assist.” For the “Arrange” step, the 
difference in size of the effect was 2.7%. The rate of women recalling the 5As at least in one 
visit changed from 41.2% to 47.5% in the intervention group (median rate change, 12.5%), 
and from 29.2% to 31.2% in the control group (median rate change, −0.1%). The 
intervention effect on recalling the 5As in at least one visit was a 12.6% (95% CI: −8.0–
30.5; P = .212) absolute increase, although not statistically significant.
The size of the effects on the rate of women recalling the 5As in Argentina and Uruguay 
were statistically different (median regression, P = .02). In Argentina, there was a 29.7% 
relative increase in the percentage of women recalling the 5As (95% CI: 12.6–46.8; P = .
002), while the effect in Uruguay was 8.5% (95% CI: 3.1–13.9; P = .004). Similarly, the 
effect on each individual component increased in both countries, with the increase for each 
component lower in Uruguay than in Argentina (Supplementary Appendix Tables 2 and 3).
The intervention group showed a statistically significant absolute increase on the rates of 
asking and advising on SHS at home and at work, compared to the control group (data not 
shown). Overall, asking about exposure at work and at home increased 24.0% (95% CI: 
10.7–40.1) and 32.8% (95% CI: 21.1–45.0), respectively. As with the 5As, the effect was 
larger in Argentina than in Uruguay: asking about exposure at work increased 24.8% (95% 
CI: −0.3–49.9) in Argentina and 13.5% (95% CI: −4.2–31.3) in Uruguay and asking about 
exposure at home increased 43.3% (95% CI: 10.8–75.7) in Argentina and 25.6% in Uruguay 
(95%CI: 16.5–34.6). Overall, advising on SHS consequences on women’s and babies’ health 
Althabe et al. Page 8













increased 30.1% (95% CI: 14.7–41.3) and 30.0% (95% CI: 15.5–44.2), respectively. Again, 
the effect was larger in Argentina than in Uruguay: advising on SHS consequences on 
women’s health increased 38.8% (95% CI: 16.4–61.3) in Argentina and 16.0% (95% CI: 
4.7–27.4) in Uruguay and advising on SHS consequences on baby’s health increased 43.5% 
(95% CI: 19.4–49.7) in Argentina and 21.3% in Uruguay (95% CI: 7.15–35.6).
The proportion of women who continued smoking during pregnancy was not reduced 
between baseline and follow-up either in the intervention or control groups (Table 3). 
Moreover, a slight statistically significant increase from baseline to follow-up in the 
proportion that continued smoking was observed in the intervention group (OR 1.14, 95% 
CI: 1.01–1.29), while no change occurred in the control group (OR 0.99, 95% CI: 0.88–
1.11). The relative difference between baseline and follow-up changes in intervention and 
control groups was not statistically significant (ROR 1.16, 95% CI: 0.98–1.37). The quit 
rates among smokers at first ANC visit decreased in both groups at follow-up. However, the 
reduction was larger in the control group but the 95% CI included 1.0 (ROR 1.29, 95% CI: 
0.84–1.97). In stratified analyses (data not shown), these trends were similar in both 
countries. We conducted a sensitivity analysis excluding women without saliva samples 
instead of treating them as smokers. The results did not change. For description purposes, 
Supplementary Appendix Table 4 reports the rates of women according their smoking status 
at baseline and follow-up by country, in intervention and control groups.
At follow-up, a questionnaire was administered to 169 and 168 ANC providers in the 
intervention and control groups, respectively. The mean response rates were 85.2% for the 
intervention group and 86.8% for the control group. Evidence-based knowledge, positive 
attitudes, and self-confidence of providers were, in general, higher than 50% in both 
intervention and control groups at both baseline and follow-up. No significant changes were 
observed in the items explored between intervention and control groups, with the exception 
of the provision to women of smoking cessation self-help materials as a barrier with an 
increase of 50.6% (95% CI: 31.4–60.0) and decrease in the perception of the lack of 
materials as a barrier at −46.4% (95% CI: −59.3 to −14.8). Similar results were found when 
we used the Z-score to percentile rank transformation or scores higher than 6 to analyze the 
Likert-scales outcomes (data not shown). The results are shown in Supplementary Appendix 
Tables 5 and 6.
 Discussion
 Summary of Findings
In this cluster RCT, we assessed the effects of a multifaceted intervention to deliver the 5As 
intervention during ANC in public clinics in Argentina and Uruguay. The intervention 
resulted in an overall increase of 17 percentage points in the frequency of women recalling 
the 5As (30% in Argentina and 9% in Uruguay). However and despite this increase, less 
than one third of the women attending the intervention clinics recalled the 5As in more than 
one visit. The intervention also increased the frequency of women recalling advice regarding 
avoiding SHS. The intervention did not significantly affect the rate of women who continued 
smoking during pregnancy, or the rate of smokers quitting during pregnancy. Additionally, a 
slight increase in the rate of women who continued smoking and a decrease in the quitting 
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rates among smokers were observed at follow-up in both groups. Finally, overall, the 
intervention did not have a significant effect on the knowledge, attitudes, and self-confidence 
of the ANC providers towards providing the 5As, which were highly positive in both 
intervention and control groups at baseline.
 Strengths and Limitations
The study had several strengths. We used a rigorous experimental design and achieved 
similar groups by using a covariate-constrained randomization approach. Careful training of 
interviewers and monitoring of data acquisition resulted in minimal missing data. The 
outcome data collection in women during the postpartum stay, conducted by data collectors 
well separated from the intervention teams, prevented observer bias of the women’s 
outcomes. The selected intervention strategies were documented as effective in changing 
behavior and were tailored according to formative research. Finally, the multifaceted 
strategy was implemented with a pragmatic approach to integrate the intervention within the 
existing health systems, suggesting that the reported effects might be similar in a programme 
using these components.
Nonetheless, the study has a few limitations. Interviewing women during the postpartum 
stay and not during pregnancy could have affected recall of the ANC process, increasing 
outcome misclassification. We cannot rule out the possibility of social desirability bias in the 
responses of women interviewed in the intervention group. However, the clear separation of 
the outcome assessment at the postpartum stay conducted in different facilities and by 
interviewers independent of the ANC clinics makes this unlikely. Also, missing biochemical 
validation was a limitation, although we used a conservative approach considering all those 
who had missing values as smokers.
 Interpretation
The intervention showed a moderate effect in increasing the proportion of women recalling 
the 5As, but, at follow-up, only a third of women in the intervention group recalled 
counseling in more than one visit. The high compliance with the intervention 
implementation at the antenatal clinic level among the intervention group suggests that the 
factors preventing a higher coverage of the 5As might be more likely related to variation in 
the behavior of the individual providers, as we found 40% of observations providers did not 
implement the 5As as required. Alternatively, the providers’ high positive attitudes and self-
confidence towards smoking cessation counseling during pregnancy suggest that the barriers 
might be more related to some characteristics of the 5As. Despite the evidence of 
effectiveness of brief cessation counseling, our findings are consistent with implementation 
challenges found in clinical practice.6,25 Clinical practice guidelines that change the existing 
routines, demand training and new skills, and require substantial organizational changes 
have been associated with lower guideline implementation.26–28 The larger effect shown on 
the frequency of women recalling SHS advice with around 60% of women recalling advice 
at follow-up compared to baseline, suggest that the main barriers to full intervention 
implementation might be in the advice to smokers. Additionally, 50% of the providers in the 
intervention group at follow-up mentioned lack of time as a barrier to providing counseling 
(Supplementary Appendix Table 6).
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Why the intervention showed a significantly differential effect in Argentina than in Uruguay 
is unclear and was unexpected. Compliance with the intervention components was similar in 
both countries, as well as the effect on rates of providers’ readiness. However, the overall 
quality of the intervention is unknown, as it was not rigorously evaluated and could have 
varied by country. These findings suggest that other areas should be further explored as 
potential factors of the differences. However, because of the pragmatic design, we did not 
systematically collect detailed process data on the intervention implementation that might be 
useful to propose alternative explanations.
The intervention did not affect either the rate of women who continued smoking or who quit 
smoking during pregnancy. The modest 17 percentage point increase in the frequency of 
women receiving the 5As between the intervention and control group, and the overall low 
percentage of women who received the 5As in more than one visit are the most likely 
explanations. The quality of the counseling might have been modest and could have 
contributed as well.
The slight increase in the rate of women who continued smoking and the decrease in the rate 
of quitters during pregnancy is a matter of concern for public health in both countries. This 
trend is not consistent with other reports that show a decline is smoking prevalence among 
women of reproductive age, including Argentina and Uruguay.29
 In Context
To our knowledge, two published trials conducted in Australia evaluated comparable 
interventions to disseminate smoking cessation programs at antenatal clinics.12,13 Cooke and 
colleagues randomly allocated clinics to two groups, which received the program of brief 
intervention for smoking cessation either by simple or intensive dissemination and trained 
midwives who provided support and training for the program. The study showed no 
differences in the adoption of the smoking cessation program between the two groups.12 
Lowe and colleagues performed a cluster RCT comparing hospitals conducting a 
behaviorally-based intervention, which included training workshops and reminders, 
compared to hospitals receiving printed materials. At 1-year follow-up, 68% of the 
intervention hospitals were providing antenatal smoking cessation to smoking pregnant 
women, compared with only 14% in the control hospitals.13 Both trials evaluated the 
intervention effect with managers and providers, a method highly susceptible to information 
bias, and did not measure the outcomes in women. Thus, our results are difficult to be 
compared.
 Implications for Practice and Policy
In summary, these results show that by deploying similar interventions it can be expected a 
modest to moderate increase (depending on the country) in the provision of brief counseling 
for smoking cessation using the 5As strategy (measured by patient recall), but not to the 
majority of women and with uncertain quality. Strategies to increase the fidelity of delivery 
of the intervention are needed if policy makers are to expect reductions in the proportion of 
smokers among pregnant women.
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 Implications for Research
Can we improve this kind of pragmatic multifaceted intervention to make it more effective to 
increase coverage and quality of the brief counseling for smoking cessation to pregnant 
women? Exploring any differential effects according to whether only a special team of 
providers or all providers counsel women will be important to orient future designs. 
Additionally, exploring the reasons for the differential effects between countries will be 
important to identify other hidden barriers and facilitators. Finally, the trends of smoking 
during pregnancy, and among low-income groups, should be closely monitored in these 
countries to assess whether our observation was isolated or was part of a more generalized 
problem.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Characteristics of Clusters, ANC Providers, and Women at Baseline and Follow-upa
Characteristics
Baseline periodb Follow-up periodc
Intervention group 
(N = 10)
Control group (N = 
10)
Intervention 




 Ratio of providers/women attending prenatal care 0.053 ± 0.027 0.051 ± 0.030
 Percentage of nurses or midwives/providers   50.6 ± 11.5   50.8 ± 18.5
Prenatal care providers
 Age (y)   44.0 ± 3.1   42.8 ± 2.5 44.2 ± 4.0 40.7 ± 5.0
 Female (%)   88.3 ± 7.4   74.9 ± 12.7 85.0 ± 9.0 85.2 ± 9.8
 Number of years since graduation   16.8 ± 2.5   16.6 ± 3.2 17.1 ± 4.0 14.3 ± 4.4
 Profession (%)
  Physician   49.5 ± 15.3   53.7 ± 17.9 50.4 ± 21.8 50.3 ± 28.1
  Midwife   29.9 ± 17.3   23.1 ± 23.0 38.3 ± 21.2 27.0 ± 23.9
  Nurses   17.3 ± 15.7   21.9 ± 14.6 10.8 ± 13.8 20.5 ± 24.3
  Other     3.2 ± 7.8     1.4 ± 2.3   0.5 ± 1.7   2.2 ± 5.4
Women’s and newborns’ characteristics
 Maternal age <20 years (%)   20.6 ± 4.4   20.8 ± 5.4 24.5 ± 5.1 22.3 ± 8.6
 Primiparous women (%)   35.5 ± 7.1   36.9 ± 7.1 42.4 ± 14.7 41.7 ± 11.5
 Number of prenatal care visits     7.9 ± 1.3     8.0 ± 1.5   7.8 ± 1.5   7.6 ± 1.5
 Recall 5As during prenatal cared (%)     4.1 ± 4.1     3.7 ± 4.6
 Continue smoking during pregnancye (%)   21.9 ± 11.1   21.8 ± 10.0
 Nonsmokers   69.1 ± 8.1   69.0 ± 9.7
 Smoke-free home rule (%)   68.0 ± 7.6   64.5 ± 9.1
 Partner/household member smokes (%)   45.9 ± 6.4   42.1 ± 4.0
 Infant’s birth weight <2500 g (%)     6.7 ± 2.3     7.5 ± 2.1
ANC = antenatal care.
a
The mean (SD) of clusters’ rates (in percent) is reported. For age and years since graduation of the prenatal care providers and for the number of 
prenatal care visits, the mean ± SD of cluster’s means is reported. No significant difference between groups at baseline or follow-up.
b
There were 192 prenatal care providers and 1562 mothers in the intervention clusters, and 166 prenatal care providers and 1771 women in the 
control clusters.
c
There were 136 prenatal care providers and 1793 mothers in the intervention clusters, and 136 prenatal care providers and 1732 women in the 
control clusters.
d
For randomization purposes only, recall of the 5As (Ask, Advise, Assess, Assist, and Arrange) was defined as nonsmokers and quitters reported 
receiving the first 2As at all visits and smokers reported recalling the 5As at all visits. This variable definition differed from the definition of the 
5As for the trial outcome measure.
e
Continued smokers were those who reported smoking every day or some days throughout pregnancy or within the last week prior to delivery.
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